PA
WST icon

Procyon Advisors’s West Pharmaceutical WST Stock Holding History

Procyon Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-65
Closed -$15K – 1067
2020
Q2 		$15K Buy
65
+6
+10% +$1.18K 0.01% 588
2020
Q1 		$9K Sell
59
-21
-26% -$3.23K 0.01% 616
2019
Q4 		$12K Buy
+80
New +$11.6K 0.01% 616

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Procyon Advisors's WST Position: Q3 2020 in Review

Procyon Advisors sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 65 shares — an estimated $15K sold.

Procyon Advisors first reported a position in WST in Q4 2019 and held it in 3 quarters. The position peaked at $15K in Q2 2020. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • Procyon Advisors reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Procyon Advisors sold 65 West Pharmaceutical shares in Q3 2020, an estimated $15K.
  • Procyon Advisors first reported a position in West Pharmaceutical in Q4 2019 and held it in 3 quarters.
  • Procyon Advisors's West Pharmaceutical position peaked at $15K in Q2 2020.
  • 574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.